Autio, K. A., Antonarakis, E. S., Mayer, T. M., Shevrin, D. H., Stein, M. N., Vaishampayan, U. N., . . . Scher, H. I. (2021). Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier.
Style de citation Chicago (17e éd.)Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.
Style de citation MLA (8e éd.)Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.